These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long term management of ventricular arrhythmias--to treat or not to treat? Talajic M Can J Cardiol; 1991 Mar; 7(2):96-7; discussion 103-4. PubMed ID: 2049689 [No Abstract] [Full Text] [Related]
6. [The variability and prognostic significance of ventricular hyperkinetic arrhythmias in the postinfarct: the considerations after the CAST. Cardiac Arrhythmia Suppression Trial]. Furlanello F; Gramegna L G Ital Cardiol; 1990 Jul; 20(7):615-7. PubMed ID: 2245899 [No Abstract] [Full Text] [Related]
7. [Risks and rules in the use of anti-arrhythmia agents]. Motté G; Sebag C Arch Mal Coeur Vaiss; 1981 Apr; 74(4):473-9. PubMed ID: 6786244 [No Abstract] [Full Text] [Related]
8. [Ventricular arrhythmias: diagnosis and drug therapy]. Schüpfer C; Gertsch M Praxis (Bern 1994); 1996 May; 85(20):647-54. PubMed ID: 8685556 [TBL] [Abstract][Full Text] [Related]
9. [Therapy of ventricular arrhythmias]. Frohner K Wien Med Wochenschr; 1984 Oct; 134(19-20):448-57. PubMed ID: 6516421 [TBL] [Abstract][Full Text] [Related]
10. New drugs and the management of ventricular arrhythmias. Heger JJ; Zipes DP J Indiana State Med Assoc; 1980 Jul; 73(7):461-6. PubMed ID: 7452037 [No Abstract] [Full Text] [Related]
11. Ventricular arrhythmias: advice from a family physician. Grauer K Am Fam Physician; 1994 Jun; 49(8):1710, 1713-4. PubMed ID: 8203308 [No Abstract] [Full Text] [Related]
12. Ventricular arrhythmias, Part III: Benefits and risks of antiarrhythmic therapy. Grauer K; Gums J J Am Board Fam Pract; 1988; 1(4):255-66. PubMed ID: 3066124 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacologic treatment of ventricular arrhythmias. General considerations and methods for evaluating its effectiveness]. Iturralde P; Bayés de Luna A; Guindo J Arch Inst Cardiol Mex; 1987; 57(1):73-6. PubMed ID: 2952094 [No Abstract] [Full Text] [Related]
17. Pharmacologic management of ventricular arrhythmias. Benz MR Crit Care Nurs Q; 1991 Nov; 14(3):8-15. PubMed ID: 1933547 [No Abstract] [Full Text] [Related]
18. [Oral propafenone in chronic ventricular arrhythmias. Prospective evaluation with the Holter monitor]. Sánchez Domínguez J; Roldán I; Navarro A; Villa JG; Urbina FJ; Barciela R; Barras C Rev Clin Esp; 1985 Nov; 177(8):372-5. PubMed ID: 3836459 [No Abstract] [Full Text] [Related]
19. [Cardiac arrhythmias (III). The classification of anti-arrhythmia drugs in the 90s: a focus for the cardiologist]. Tamargo J; Valenzuela C; Delpón E Rev Esp Cardiol; 1993 Mar; 46(3):183-94. PubMed ID: 8387683 [No Abstract] [Full Text] [Related]
20. Effects of KO 1173 on ventricular arrhythmias. Campbell N; Kelly J; Strong J; Shanks RG; Pantridge JF Br Heart J; 1973 May; 35(5):559. PubMed ID: 4716041 [No Abstract] [Full Text] [Related] [Next] [New Search]